help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stanley, E. L.
Right arrow Articles by Coughtrie, M. W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stanley, E. L.
Right arrow Articles by Coughtrie, M. W. H.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 12 5944-5955
Copyright © 2001 by The Endocrine Society


Other Original Articles

Differential Expression of Sulfotransferase Enzymes Involved in Thyroid Hormone Metabolism during Human Placental Development

Emma L. Stanley, Robert Hume, Theo J. Visser and Michael W. H. Coughtrie

Departments of Molecular and Cellular Pathology (E.L.S., R.H., M.W.H.C.) and Obstetrics and Gynaecology (E.L.S., R.H.), University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, United Kingdom; and Department of Internal Medicine (T.J.V.), Erasmus University Medical School, 3015 GD Rotterdam, The Netherlands

Address all correspondence and requests for reprints to: Dr. Michael Coughtrie, Department of Molecular and Cellular Pathology, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, United Kingdom. E-mail: m.w.h.coughtrie{at}dundee.ac.uk

Abstract

Thyroid hormone is essential for normal human development, and disruption of thyroid hormone homeostasis at critical developmental stages can result in severe and often long-term effects on crucial organs such as the brain and lungs. Numerous factors control the bioavailability of receptor active thyroid hormone T3. Sulfation, catalyzed by sulfotransferase enzymes (SULTs), is an important pathway of thyroid hormone metabolism by which T4 is irreversibly converted to inactive reverse T3 rather than active T3. The human fetus and neonate have high levels of circulating sulfated iodothyronines, although the source of these is not clear. The placenta forms the link between the fetus and its mother and is involved in transfer of thyroid hormone early in pregnancy, although its capacity for sulfation is unknown. We therefore examined expression of the SULTs involved in iodothyronine metabolism during human placental development. SULT activity was measured in human placental cotyledon and membranes (amnion, chorion, and decidua basalis) from 13–42 wk of gestation, and Western blot analysis was employed to verify enzyme activity data. Phenol and catecholamine sulfotransferases were expressed at the highest levels and were generally higher in the villous than membranous tissues. SULT1A1 activity showed significant correlation with sulfation of 3,3'-T2, suggesting that this enzyme is primarily responsible for placental T2 sulfation. Estrogen sulfotransferase was present at extremely low levels during early pregnancy, although in mid- and late gestation increased expression in the (predominantly maternal-derived) decidual component of the placenta was observed. Hydroxysteroid sulfotransferase, T3, reverse T3, and T4 SULT activities were also low in all tissues examined, and expression of SULTs 1B1 and 1C2 were essentially undetectable by Western blot analysis. The results highlight a tissue-specific regulation of SULT expression during placental development, demonstrate very low sulfation of iodothyronines suggesting that the placenta is not a major source of circulating sulfated iodothyronines in the fetus.




This article has been cited by other articles:


Home page
J EndocrinolHome page
S-Y Chan, J A Franklyn, H N Pemberton, J N Bulmer, T J Visser, C J McCabe, and M D Kilby
Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.
J. Endocrinol., June 1, 2006; 189(3): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Hempel, H. Wang, E. L. LeCluyse, M. E. McManus, and M. Negishi
The Human Sulfotransferase SULT1A1 Gene Is Regulated in a Synergistic Manner by Sp1 and GA Binding Protein
Mol. Pharmacol., December 1, 2004; 66(6): 1690 - 1701.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Hume, J. Simpson, C. Delahunty, H. van Toor, S. Y. Wu, F. L. R. Williams, and T. J. Visser
Human Fetal and Cord Serum Thyroid Hormones: Developmental Trends and Interrelationships
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4097 - 4103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. U. Gamage, R. G. Duggleby, A. C. Barnett, M. Tresillian, C. F. Latham, N. E. Liyou, M. E. McManus, and J. L. Martin
Structure of a Human Carcinogen-converting Enzyme, SULT1A1. STRUCTURAL AND KINETIC IMPLICATIONS OF SUBSTRATE INHIBITION
J. Biol. Chem., February 21, 2003; 278(9): 7655 - 7662.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society